期刊文献+

岳阳地区头孢他啶使用量与鲍曼不动杆菌耐药性的相关性分析

Correlativity Analysis on Consumption of Ceftazidime and Drug Resistance of Acinetobacter baumannii in Yueyang
原文传递
导出
摘要 目的了解本地区抗菌药物尤其是头孢他啶使用量的变化,探讨其对鲍曼不动杆菌(Ab)耐药情况的影响。方法统计本地区2007-2008年用药人/次排序列前9位的抗菌药物使用量与Ab耐药率,并进行相关性分析。结果头孢他啶使用量与下季度Ab对头孢他啶和其它7种抗菌药的耐药率呈线性关系(P<0.05),其它结果差异无统计学意义。结论头孢他啶的使用量与Ab对多种抗菌药物耐药性的发展有关。 Objective To study the change of consumption of antibacterial agents, especially the ceftazidime and its effect on drug resistance of Acinetobacter baumannii (Ab). Methods The consumption of the top ten antimicrobial agents in terms of person/times of medication from 2007 to 2008 in a hospital and its correlation with the drug resistance of Acineto- bacter baumannii were analyzed. Results A linear correlation was noted between the consumption of ceftazidime and resis- tance of Pseudomonas aeruginosa to ceftazidime and other seven antimicrobial agents in the next quarter (P〈 0.05), howev- er, there was no statistically significant difference among all the other results. Conclusions The consumption of ceftazi- dime is associaied with resistance of Acinetobacter baumannii to multi - kinds of antibacterials.
出处 《实用预防医学》 CAS 2009年第3期922-924,共3页 Practical Preventive Medicine
关键词 鲍曼不动杆菌 头孢他啶 药物利用 耐药 Acinetobacter baumannii Ceftazidime Drug utilization Drug resistance
  • 相关文献

参考文献4

二级参考文献19

  • 1[1]Bou G, Oliver A, Martrinez J, et al. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain[J]. Antimicrob Agents Chemother, 2000, 44(6): 1556-1561.
  • 2[2]Iregbu K C, Ogunsola F T, Odugbemi T O. Infections caused by Acinetobacter species and their susceptibility to 14 antibiotics in Lagos University Teaching Hospital, Lagos[J]. West Afr J med, 2002, 21(3): 226-229.
  • 3[3]Scerpella E G, Wanger A R, Armitige L, et al. Nosocomial outbreak caused by 9 multiresistance clone of Acinetobacter baumannii; results of the case control and molecular epidemiologic investigations[J]. Infect Control Hosp Epidemiol, 1995, 16(2): 92-97.
  • 4[5]Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, et al. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J]. J Antimicrob Chemother, 2003, 51(3): 565-74.
  • 5[6]Gales A C, Tognim M C, Reis A O, et al. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital[J]. Diagn Microbiol Infect Dis, 2003, 45(1): 77-79.
  • 6[8]Rodriguez-Bano J, Pascual A, Gavez J, et al. Acinetobacter baumannii bacteremia: clinical and prognostic features[J]. Enferm Infect Microbiol Clin, 2003, 21(5): 242-277.
  • 7Roussel-Delvallez M,Wallet F,Delpierre F,et al.In vitro bactericidal effect of a beta-lactam + aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii [J].J Chemother ,1996,8(5) :365
  • 8Afzal-Shan M,Woodford N,Livermore DM.Characterization of OXA-25,OXA-26,and OXA-27,molecular class D β-Lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannnii [J].Antimicrob Agents Chemother ,2001,45(2):583
  • 9Guenthner SH,Hendley JQ,Wenzel RP.Gram-negative bacilli as nontransient flora on the hands of hospital personnel [J].J Clin Microb ,1987,25(3) :488
  • 10Vila J,Ruiz J,Goni P,Marcos A,et al.Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii [J].Antimicrob Agents Chemother ,1995,39(5) :1201

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部